SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-09-033303
Filing Date
2009-06-18
Accepted
2009-06-18 16:31:01
Documents
1
Effectiveness Date
2009-06-18

Document Format Files

Seq Description Document Type Size
1 v152612_defa14a.htm DEFA14A 65939
  Complete submission text file 0001144204-09-033303.txt   67381
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEFA14A | Act: 34 | File No.: 000-25169 | Film No.: 09899068
SIC: 2834 Pharmaceutical Preparations